However, recent studies have detected a sustained high level of EETs by upregulated CYP2C8, 2C9 and 2J2, or downregulated sEH in various cancers such as renal, lung, basal cell, bladder, ovarian, colon, and prostate cell carcinomas [3, 7, 10, 22]. Here, EPHX2 is linked to cancer.